OOIR: Observatory of International Research

Papers

(The median citation count of BJU International is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)

Article	Citations
The rising worldwide impact of benign prostatic hyperplasia	91
Is off‐clamp robot‐assisted partial nephrectomy beneficial for renal function? Data from the CLOCK trial	69
Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation	67
TikTok and prostate cancer: misinformation and quality of information using validated questionnaires	64
Guideline of guidelines: management of recurrent urinary tract infections in women	51
Robot‐assisted radical prostatectomy feasibility and setting with the Hugo™ robot‐assisted surgery system	48
The cancer multidisciplinary team meeting: in need of change? History, challenges and future perspectives	47
Systemic therapies for metastatic hormone‐sensitive prostate cancer: network meta‐analysis	42
Deep learning approach to predict lymph node metastasis directly from primary tumour histology in prostate cancer	42
UpFrontPSMA: a randomized phase 2 study of sequential ¹⁷⁷Lu‐PSMA‐617 and docetaxel vs docetaxel in metastatic hormone‐naïve prostate cancer (clinical trial protocol)	42
Impact of the SARS‐CoV‐2 virus on male reproductive health	42
Objective assessment of intraoperative skills for robot‐assisted radical prostatectomy (RARP): results from the ERUS Scientific and Educational Working Groups Metrics Initiative	39
International Alliance of Urolithiasis guideline on retrograde intrarenal surgery	39
Prostate cancer in transgender women: what does a urologist need to know?	38
The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer – a multicentre observational study	35
Certification in reporting multiparametric magnetic resonance imaging of the prostate: recommendations of a UK consensus meeting	34
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy	32
Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)	32
Current status of thulium fibre laser lithotripsy: an up‐to‐date review	32
Feasibility and safety of radical prostatectomy for oligo‐metastatic prostate cancer: the Testing Radical prostatectomy in men with prostate cancer and oligo‐Metastases to the bone (TRoMbone) trial	32
Impact of the COVID‐19 pandemic on the diagnosis and treatment of men with prostate cancer	31
Thulium fibre laser vs holmium: yttrium‐aluminium‐garnet laser lithotripsy for urolithiasis: meta‐analysis of clinical studies	31
Every decade counts: a narrative review of functional recovery after partial nephrectomy	31
Local anaesthetic transperineal (LATP) prostate biopsy using a probe‐mounted transperineal access system: a multicentre prospective outcome analysis	30
Association of erectile dysfunction and cardiovascular disease: an umbrella review of systematic reviews and meta‐analyses	30

The impact of racial residential segregation on prostate cancer diagnosis and treatment	28
Predictors of local recurrence and its impact on survival after glansectomy for penile cancer: time to challenge the dogma?	27
Upper urinary tract pressures in endourology: a systematic review of range, variables and implications	27
Cancer‐associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti‐angiogenic therapy	26
The dramatic COVID 19 outbreak in Italy is responsible of a huge drop of urological surgical activity: a multicenter observational study	26
NeuroSAFE frozen section during robot‐assisted radical prostatectomy: peri‐operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trial	25
Rising incidence rates and unaltered survival rates for primary upper urinary tract urothelial carcinoma: a Dutch population‐based study from 1993 to 2017	25
Holmium laser enucleation of the prostate using Moses 2.0 vs non‐Moses: a randomised controlled trial	25
Toward improved endoscopic examination of urinary stones: a concordance study between endoscopic digital pictures vs microscopy	24
Rezūm therapy for ≥80‐mL benign prostatic enlargement: a large, multicentre cohort study	23
Open vs robot‐assisted radical cystectomy (BORARC): a double‐blinded, randomised feasibility study	22
Assessment of prostate‐specific antigen screening: an evidence‐based report by the German Institute for Quality and Efficiency in Health Care	22
Exercise training to increase tumour natural killer‐cell infiltration in men with localised prostate cancer: a randomised controlled trial	22
Towards automatic recognition of pure and mixed stones using intra‐operative endoscopic digital images	22
ENZA‐p trial protocol: a randomized phase II trial using prostate‐specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration‐resistant prostate cancer	22
Robot‐assisted pyeloplasty using a new robotic system, the KangDuo‐Surgical Robot‐01: a prospective, single‐centre, single‐arm clinical study	21
Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation	21
Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt test	21
Impact of enhanced optical techniques at time of transurethral resection of bladder tumour, with or without single immediate intravesical chemotherapy, on recurrence rate of non‐muscle‐invasive bladde	21
Multi‐institutional validation of a perfused robot‐assisted partial nephrectomy procedural simulation platform utilizing clinically relevant objective metrics of simulators (CROMS)	21
Multicentre, prospective study on local treatment of metastatic prostate cancer (LoMP study)	21
Pubectomy and urinary reconstruction provides definitive treatment of urosymphyseal fistula following prostate cancer treatment	20
Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta‐analysis	20
Environmental impact of single‐use and reusable flexible cystoscopes	20
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma	19
Natural history of small asymptomatic kidney and residual stones over a long‐term follow‐up: systematic review over 25 years	19
Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate	19
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes	19
Social media and misinformation in urology: what can be done?	19
Comparing the outcomes of open, laparoscopic and robot‐assisted partial nephrectomy: a network meta‐analysis	19
Morbidity and mortality after robot‐assisted radical cystectomy with intracorporeal urinary diversion in octogenarians: results from the European Association of Urology Robotic Urology Section Scienti	18
Reduction of stent‐associated morbidity by minimizing stent material: a prospective, randomized, single‐blind superiority trial assessing a customized ‘suture stent’	18
The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening	18
Low‐intensity shockwave therapy for the management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta‐analysis	18
NeuroSAFE in radical prostatectomy increases the rate of nerve‐sparing surgery without affecting oncological outcome	18
A novel tool to predict functional outcomes after robot‐assisted radical prostatectomy and the value of additional surgery for incontinence	18
Implementation of frailty preoperative assessment to predict outcome in patients undergoing urological surgery: a systematic review and meta‐analysis	18
Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?	17
Median 5‐year outcomes of primary focal irreversible electroporation for localised prostate cancer	17
Longitudinal follow‐up and performance validation of an mRNA‐based urine test (Xpert^® Bladder Cancer Monitor ) for surveillance in patients with non‐muscle‐invasive bladder cancer	17
Management of uncomplicated recurrent urinary tract infections	17
Blue vs white light for transurethral resection of non‐muscle‐invasive bladder cancer: an abridged Cochrane Review	17
Tranexamic acid in patients with complex stones undergoing percutaneous nephrolithotomy: a randomised, double‐blinded, placebo‐controlled trial	17
Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis	17
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma	17
Population‐based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study	16
Urine cell image recognition using a deep‐learning model for an automated slide evaluation system	16
Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high‐risk upper tract urothelial carcinoma: a multicentre retrospective study	16
Evaluation and understanding of automated urinary stone recognition methods	16
Recovery of health‐related quality of life in patients undergoing robot‐assisted radical cystectomy with intracorporeal diversion	16

Event‐free survival after radical prostatectomy according to prostate‐specific membrane antigen‐positron emission tomography and European Association of Urology biochemical recurrence risk	16
Urological stone disease: a 5‐year update of stone management using Hospital Episode Statistics	15
The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non‐muscle‐invasive bladder cancer treated with bacillus Calmette–Guérin	15
Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME)	15
Value of tumour‐infiltrating immune cells in predicting response to intravesical BCG in patients with non‐muscle‐invasive bladder cancer: a systematic review and meta‐analysis	15
Risk models for recurrence and survival after kidney cancer: a systematic review	15
Retzius‐sparing versus standard robot‐assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer	15
Pre‐versus postnatal presentation of posterior urethral valves: a multi‐institutional experience	15
Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?	15
Learning curve analysis of single‐port robot‐assisted extraperitoneal prostatectomy using the cumulative sum (CUSUM) method	15
Primary Gleason grade and Gleason grade group at positive surgical margins: a systematic review and meta‐analysis	14
Multiparametric magnetic resonance imaging facilitates reclassification during active surveillance for prostate cancer	14
Nerve‐sparing robot‐assisted radical prostatectomy with the HUGO™ robot‐assisted surgery system using the ‘Aalst technique’	14
Perioperative outcomes and cost of robotic vs open simple prostatectomy in the modern robotic era: results from the National Inpatient Sample	14
Growth and renal function dynamics of renal oncocytomas in patients on active surveillance	14
Impact of circulating microRNA test (miRNA‐371a‐3p) on appropriateness of treatment and cost outcomes in patients with Stage I non‐seminomatous germ cell tumours	14
British Association of Urological Surgeons (BAUS) and Nurses (BAUN) consensus document: management of the complications of long‐term indwelling catheters	14
Urinary incontinence and use of incontinence surgery after radical prostatectomy: a national study using patient‐reported outcomes	14
Long‐term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis	14
Novel syphon ureteric access sheath has the potential to improve renal pressures and irrigant flow	14
Open versus robot‐assisted radical cystectomy: pentafecta and trifecta achievement comparison from a randomised controlled trial	14
Spontaneous (idiopathic) rupture of the urinary bladder: a systematic review of case series and reports	14
Incidence of testicular cancer in trans women using gender‐affirming hormonal treatment: a nationwide cohort study	13
Management of chronic primary pelvic pain syndromes	13
Incidence and risk factor analysis of complications after sentinel node biopsy for penile cancer	13
Ten‐year survival outcomes after radical nephroureterectomy with a risk‐stratified approach using prior diagnostic ureteroscopy: a single‐institution observational retrospective cohort study	13
Perioperative continuation of aspirin, oral anticoagulants or bridging with therapeutic low‐molecular‐weight heparin does not increase intraoperative blood loss and blood transfusion rate in cystectom	13
High prostate‐specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI‐RADS score 4 or 5 confers a high probability of	13
Robot‐assisted fluoroscopy‐guided renal puncture for endoscopic combined intrarenal surgery: a pilot single‐centre clinical trial	13
Optimal pathological response after neoadjuvant chemotherapy for muscle‐invasive bladder cancer: results from a global, multicentre collaboration	13
Comprehensive review of the use of hydrogel spacers prior to radiation therapy for prostate cancer	13
Masculinizing surgery in disorders/differences of sex development: clinician‐ and participant‐evaluated appearance and function	13
Complete metabolic response with [¹⁸F]fluorodeoxyglucose‐positron emission tomography/computed tomography predicts survival following induction chemotherapy and radical cystectomy in clinic	13
A non‐inferiority comparative analysis of micro‐ultrasonography and MRI‐targeted biopsy in men at risk of prostate cancer	13
Intermediate‐ and long‐term oncological outcomes of active surveillance for localized renal masses: a systematic review and quantitative analysis	13
Magnetic resonance imaging‐guided transurethral ultrasound ablation in patients with localised prostate cancer: 3‐year outcomes of a prospective Phase I study	12
Percutaneous nephrolithotomy – the puncture	12
Evaluation of fluid absorption during flexible ureteroscopy in an in vivo porcine model	12
Stress urinary incontinence in the mesh complication era: current Australian trends	12
What influences adherence to guidance for postoperative instillation of intravesical chemotherapy to patients with bladder cancer?	12
Ejaculatory function following transperineal laser ablation vs TURP for benign prostatic obstruction: a randomized trial	12
Early detection of kidney cancer using urinary proteins: a truly non‐invasive strategy	12
British Association of Urological Surgeons (BAUS) consensus document: management of bladder and ureteric injury	12
First‐line programmed death receptor‐1 (PD‐1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum‐based chemotherapy, for stage IV penile cance	12
Understanding the needs of low‐income countries: how urologists can help	12
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions	12
The prognostic value of lymph node staging with prostate‐specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and extended pelvic	12
Renal oncocytoma: landscape of diagnosis and management	12
Medical treatment of recurrent ischaemic priapism: a review of current molecular therapeutics and a new clinical management paradigm	12
Idea, Development, Exploration, Assessment, Long‐term follow‐up study (IDEAL) Stage 1/2a evaluation of urological procedures with the Versius robot	12
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma	11
Step‐by‐step technique for the endoscopic treatment of ureteric stricture	11
Considering non‐bladder aetiologies of overactive bladder: a functional neuroimaging study	11
Xanthogranulomatous pyelonephritis: a systematic review of treatment and mortality in more than 1000 cases	11
Prognostic scoring system and risk stratification in patients with emphysematous pyelonephritis: an 11‐year prospective study at a tertiary referral centre	11
Outcomes of the RAFT trial: robotic surgery after focal therapy	11
Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta‐analysis	11
Patterns of care for prostate cancer treatment and improving outcomes – are national registries the answer?	11
Personalised three‐dimensional printed transparent kidney model for robot‐assisted partial nephrectomy in patients with complex renal tumours (R.E.N.A.L. nephrometry score ≥7): a prospective case‐matc	11
Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique	11
The rapid assessment for prostate imaging and diagnosis (RAPID) prostate cancer diagnostic pathway	11
A phase I open label dose‐escalation study to evaluate the tolerability, safety and immunological efficacy of sub‐urothelial durvalumab injection in adults with muscle‐invasive or high‐risk non‐muscle	11
Elevated preoperative C‐reactive protein is associated with renal functional decline and non‐cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consort	11
A cross‐section of UK prostate cancer diagnostics during the coronavirus disease 2019 (COVID‐19) era – a shifting paradigm?	10
Diagnosis, treatment and survival from bladder, upper urinary tract, and urethral cancers: real‐world findings from NHS England between 2013 and 2019	10
Standardised uptake values as determined on prostate‐specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer	10
A prehabilitation programme implemented before robot‐assisted radical prostatectomy improves peri‐operative outcomes and continence recovery	10
A novel flexible vacuum‐assisted ureteric access sheath in retrograde intrarenal surgery	10
Three‐arms off‐clamp robot‐assisted partial nephrectomy with the new Hugo robot‐assisted surgery system	10
Salvage irreversible electroporation for radio‐recurrent prostate cancer – the prospective FIRE trial	10
Predicting early outcomes in patients with intermediate‐ and high‐risk prostate cancer using prostate‐specific membrane antigen positron emission tomography and magnetic resonance imaging	10
Healthcare lockdown resulted in a treatment backlog in elective urological surgery during COVID‐19	10
Risk factors and natural history of parastomal hernia after radical cystectomy and ileal conduit	10
Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy	10
Cost‐effectiveness analysis of multiple imaging modalities in diagnosis and follow‐up of intermediate complex cystic renal lesions	10
External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic reson	10
Confocal laser microscopy for assessment of surgical margins during radical prostatectomy	9
Utility of blood tests in screening for metabolic disorders in kidney stone disease	9
Low‐grade prostate cancer should still be labelled cancer	9
A randomized trial investigating clinical outcomes and stent‐related symptoms after placement of a complete intra‐ureteric stent on a string versus conventional stent placement	9

Ureteroscopy and tailored treatment of upper tract urothelial cancer: recent advances and unmet needs	9
High diagnostic accuracy of inguinal ultrasonography and fine‐needle aspiration followed by dynamic sentinel lymph node biopsy in men with impalpable and palpable inguinal lymph nodes	9
UK practice for penile prosthesis surgery: baseline analysis of the British Association of Urological Surgeons (BAUS) Penile Prosthesis Audit	9
Functional recovery after partial nephrectomy: next generation analysis	9
Intravesical mitomycin C (MMC) and MMC + cytosine arabinoside for non‐muscle‐invasive bladder cancer: a randomised clinical trial	9
Defining prostate cancer size and treatment margin for focal therapy: does intralesional heterogeneity impact the performance of multiparametric MRI?	9
Urological litigation trends in the UK National Health Service: an analysis of claims over 20 years	9
Median 4‐year outcomes of salvage irreversible electroporation for localized radio‐recurrent prostate cancer	9
Application of artificial intelligence to overcome clinical information overload in urological cancer	9
Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer	9
Potential safety concerns in use of the artificial intelligence chatbot ‘ChatGPT’ for perioperative patient communication	9
Complications of synthetic mesh inserted for stress urinary incontinence	9
Development of a patient decision aid for the surgical management of lower urinary tract symptoms secondary to benign prostatic hyperplasia	9
A comparison of prostate cancer prediction models in men undergoing both magnetic resonance imaging and transperineal biopsy: Are the models still relevant?	8
The bacterial microbiota of Hunner lesion interstitial cystitis/bladder pain syndrome	8
LEARN: a multicentre, cross‐sectional evaluation of Urology teaching in UK medical schools	8
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis	8
How to evaluate a flexible ureterorenoscope? Systematic mapping of existing evaluation methods	8
Causes and prevention of kidney stones: separating myth from fact	8
Outcomes in robot‐assisted partial nephrectomy for imperative vs elective indications	8
Robot‐assisted Boari flap and psoas hitch ureteric reimplantation: technique insight and outcomes of a case series with ≥1 year of follow‐up	8
LUNAR: a randomized Phase 2 study of ¹⁷⁷Lutetium‐PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol)	8
Loop‐tail stents fail in reducing stent‐related symptoms: results of a prospective randomised controlled trial	8
Hexylaminolevulinate‐mediated fluorescent urine cytology with a novel automated detection technology for screening and surveillance of bladder cancer	8
Association between one‐time prostate‐specific antigen (PSA) test with free/total PSA ratio and prostate cancer mortality: A 30‐year prospective cohort study	8
Electronic medical records – a disappointing mirage for clinicians and research	8
Predictive value of immunological markers after bacille Calmette–Guérin induction in bladder cancer	8
Conspicuity of cribriform prostate cancer on multiparametric magnetic resonance imaging: the jury is still out	8
A longitudinal study evaluating interim assessment of neoadjuvant chemotherapy for bladder cancer	8
A BURST‐BAUS consensus document for best practice in the conduct of scrotal exploration for suspected testicular torsion: the Finding Consensus for Orchidopexy in Torsion (F	8
Optimized detection of germ cell neoplasia in situ in contralateral biopsy reduces the risk of second testis cancer	8
Comprehensive analysis of paediatric pelvic fracture urethral injury: a reconstructive centre experience	8
Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancer	8
Establishing a sustainable healthcare environment in low‐ and middle‐income countries	8
Magnetic resonance imaging‐guided transurethral ultrasound ablation for benign prostatic hyperplasia: 12‐month clinical outcomes of a phase I study	8
Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID‐19) pandemic: an international accelerated consensus statement	8
British Association of Urological Surgeons (BAUS) consensus document: Management of female voiding dysfunction	8
A prostate biopsy risk calculator based on MRI: development and comparison of the Prospective Loyola University multiparametric MRI (PLUM) and Prostate Biopsy Collaborative Group	8
Reduced‐dose bacillus Calmette‐Guérin (BCG) in an era of BCG shortage: real‐world experience from a tertiary cancer centre	8
Pain and anxiety during vasectomies while distracting patients with video glasses or virtual reality glasses	8
Reversing the effects of androgen‐deprivation therapy in men with metastatic castration‐resistant prostate cancer	8
Oncological benefit of re‐resection for T1 bladder cancer: a comparative effectiveness study	7
Incidence of and mortality from Bacille Calmette‐Guérin (BCG) infections after BCG instillation therapy	7
Temporal development of unfavourable urodynamic parameters during the first year after spinal cord injury	7
The clinical characteristics of patients with primary non‐prostate‐specific membrane antigen‐expressing prostate cancer on preoperative positron emission tomography/computed tomography	7
The current state of genetic risk models for the development of kidney cancer: a review and validation	7
Large variation in conservative management of low‐risk prostate cancer in Australia and New Zealand	7
How reliable are surgeon‐reported data? A comparison of the British Association of Urological Surgeons radical prostatectomy audit with the National Prostate Cancer Audit Hospital Episode Statistics‐l	7
Bioengineering solutions for ureteric disorders: clinical need, challenges and opportunities	7
Long‐term renal function in patients with chronic kidney disease following radical cystectomy and orthotopic neobladder	7
Flexible fibre optic vs digital ureteroscopy and enhanced vs unenhanced imaging for diagnosis and treatment of upper tract urothelial carcinoma (UTUC): results from the Clinical Research Office of the	7
Outcomes of freehand transperineal prostate biopsy with omission of antibiotic prophylaxis	7
The modified International Society of Urological Pathology system improves concordance between biopsy and prostatectomy tumour grade	7
Music during flexible cystoscopy for pain and anxiety – a patient‐blinded randomised control trial	7
Rapid and precise delivery of cells in the urethral sphincter complex by a novel needle‐free waterjet technology	7
The Triple‐Tracer strategy against Metastatic PrOstate cancer (3TMPO) study protocol	7
The impact of smoking on sexual function	7
A randomized trial of holmium laser vs thulium laser vs bipolar enucleation of large prostate glands	7
Impact of COVID‐19 on the management and outcomes of ureteric stones in the UK: a multicentre retrospective study	7
Outcomes of robot‐assisted urinary sphincter implantation for male neurogenic urinary incontinence	6
Microwave focal therapy of prostate cancer: a non‐clinical study and exploratory clinical trial	6
Proficiency‐based progression training for robotic surgery skills training: a randomized clinical trial	6
Repeat MRI during active surveillance: natural history of prostatic lesions and upgrading rates	6
The role of nephrectomy in metastatic renal cell carcinoma in the immuno‐oncology era	6
Suprapubic catheterisation: a study of 1000 elective procedures	6
Mechanism of urosepsis: relationship between intrarenal pressures and pyelovenous backflow	6
Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicators	6
Opportunistic prostate‐specific antigen testing in Norwegian men: a public health challenge	6
Radiological features characterising indeterminate testes masses: a systematic review and meta‐analysis	6
Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node‐positive bladder cancer	6
Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate	6
Robot‐assisted retroperitoneal lymph node dissection: a systematic review of perioperative outcomes	6
Surgical outcomes and proposal for a treatment algorithm for urethral strictures in transgender men	6
Indwelling stents cause obstruction and induce ureteral injury and fibrosis in a porcine model	6
Machine‐learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR‐15)	6
In vivo ureteroscopic intrarenal pressures and clinical outcomes: a multi‐institutional analysis of 120 consecutive patients	6
Pathological predictors of ¹⁸F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy	6
Mucosal‐sparing augmented non‐transected anastomotic (MsANTA) urethroplasty: a step forward in ANTA urethroplasty	6
Time interval from transurethral resection of bladder tumour to bacille Calmette–Guérin induction does not impact therapeutic response	6
Estimating the health‐related quality of life of kidney stone patients: initial results from the Wisconsin Stone Quality of Life Machine‐Learning Algorithm (WISQOL‐MLA)	6
A systematic review on the outcomes of local anaesthetic transperineal prostate biopsy	6
Prostate cancer grading, time to go back to the future	6
Pathological features of Prostate Imaging Reporting and Data System (PI‐RADS) 3 MRI lesions in biopsy and radical prostatectomy specimens	6
Impact of age >70 years on oncological outcomes in patients with non‐muscle‐invasive bladder cancer treated with Bacillus Calmette–Guérin	6
Women doctors in female urology: current status and implications for future workforce	6
Retrospective first‐in‐human use of the LithoVue™ Elite ureteroscope to measure intrarenal pressure	6
Prognostic importance of concomitant non‐regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer	6
Initial safety outcomes for the Rigicon Infla10® inflatable penile prosthesis	6
Role of blue‐light cystoscopy in detecting invasive bladder tumours: data from a multi‐institutional registry	6
Outcomes from a prospectively implemented protocol using apixaban after robot‐assisted radical cystectomy	6
Impact of worsening surgically induced chronic kidney disease (CKD‐S) in preoperative CKD‐naïve patients on survival in renal cell carcinoma	6
Stone disease in low‐ and middle‐income countries: could augmented reality have a role in its management?	6
Versius robotic surgical system: case series of 18 robot‐assisted radical prostatectomies	6
Nomograms including the UBC^® Rapid test to detect primary bladder cancer based on a multicentre dataset	6
Impact of centralization of prostate cancer services on the choice of radical treatment	6